Insulin and the prevention of insulin-dependent diabetes mellitus

Diabetes and Metabolism

Volumn 23, Issue SUPPL. 3, 1997, Pages 25-28

  Coutant, R ^a   Carel, J C ^a   Timsit, J ^b   Boitard, C ^b   Bougneres P ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Hospital   (France)

Author keywords

Insulin; Insulin dependent diabetes; Oral route; Prevention

Indexed keywords

AUTOANTIGEN; INSULIN;

AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; ORAL DRUG ADMINISTRATION; PROPHYLAXIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AUTOANTIGENS; B-LYMPHOCYTES; CHROMOSOME MAPPING; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN;

EID: 0030846831     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Yki-Jarvincn H, Koivisto VA. Natural course of insulin resistance in type 1 diabetes. N Engl J Med, 1986, 315, 224-230.
2. Kennedy GC, German MS, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genetics, 1995, 9, 1995 ; 292-298.
3. Bennett ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type 1 diabetes at 1DDM2 is determined by tandem repeat variation at the insulin gene minisateliite locus. Nature Genetics, 1995, 9, 284-292.
4. Carel JC, Boitard C, Bougnères PF. Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children. J Clin Invest, 1993, 92, 509-513.
5. Metcalfe KA, Hitman GA, Fennessy MJ, et al. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. Diabetologia, 1995, 38, 1223-1229.
6. Vardi P, Dibella EE, Pasquarcllo TJ, Srikanta S. Islet cell autoantibodies : pathobiology and clinical applications. Diabetes Care, 1987, 10, 645-656.
7. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature, 1993, 366, 72-75.
8. Wegmann DR, Norbury Glaser M, Daniel D. Insulin-specific T cells are a predominant component of islet infliltrates in pre-diabetic NOD mice. Eur J Immunol. 1994, 24, 1853-1857.
9. Wegmann DR, Gill RG, Norbury Glaser M, Schloot N, Daniel D. Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun, 1994, 7, 833-843.
10. Lipes MA, Cooper EM, Skelly R, et al. Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc. Nail. Acad Sci USA, 1996, 93, 8595-8600.
11. Gottlieb PA, Handler ES, Appel MC, Greiner DL, Mordes JP, Rossini AA. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats. Diabetologia, 1991, 34, 296-300.
12. Alkinson MA, Maclaren NK, Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes, 1990, 39, 933-937.
13. Gotfredsen CF, Buschard K, Frandsen EK. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia, 1985, 28, 933-935.
14. Helderman JH. The insulin receptor on activated immunocompetent cells. Exp. Gerontol. 1993, 28, 323-327.
15. Thivolet CH, Goillot E, Bedossa P, Durand A, Bonnard M, Orgiazzi J. Insulin prevents adoptive cell tranfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia, 1991, 34, 314-319.
16. Vlahos WD, Sccmayer TA, Yale JF. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism, 1991, 40, 825-829.
17. Bock T, Kjaer TW, Jorgensen M, Josefsen K, Rygaard J, Buschard K. A.P.M.I.S. 1991, 99, 989-992.
18. Muir A, Peck A, Clare-Salzler M. et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest, 1995, 95, 628-634.
19. Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med. 1989, 320, 550-554.
20. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet, 1993, 341, 927-928.